At a glance
- Originator Aventis
- Class Antiasthmatics; Bronchodilators; Small molecules
- Mechanism of Action Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 04 Mar 1997 No-Development-Reported for Asthma in United Kingdom (Unknown route)